Research Article
Cardiorenal Syndrome Type 5: In Vitro Cytotoxicity Effects on Renal Tubular Cells and Inflammatory Profile
Table 1
Clinical and biochemistry parameter about CRS Type 5 patients enrolled.
| | CRS Type 5 patients |
| Female () | 3/11 | Age (years) | | Creatinine baseline (mg/dL) | 1.06 (0.95–1.41) | eGFR baseline (mL/min/1.73 m2) | 62 (50–75) | Creatinine admission (mg/dL) | 1.85 (0.77–3.64) | eGFR admission (mL/min/1.73 m2) | 36 (17.5–86) | Temperature (°C) | 38.3 (36.1–38.9) | Urine output (mL/day) | 3040 (1542–3225) | Urea (mg/dl) | 91 (59–192) | Na (mEq/L) | 138 (135–144) | K (mEq/L) | 3.9 (3.67–4.1) | White blood cells (/mm3) | 10.8 (7.25–14.2) | Platelets (/mm3) | 133 (109–149) | PaO2/FiO2 | 241.5 (194.5–273.5) | Nonsurvivors () | 3/11 | CRRT () | 4/11 |
|
|